G1 Therapeutics to Provide First Quarter 2021 Financial Results and Business Update on May 5, 2021
April 28 2021 - 9:00AM
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology
company, will host a webcast and conference call to provide a
corporate and financial update for the first quarter of 2021 on
Wednesday, May 5, 2021 at 4:30 p.m. ET.
The live call may be accessed by dialing (866) 763-6020
(domestic) or (210) 874-7713 (international) and entering the
conference code: 2509548. The live and archived webcast will be
available on the Events & Presentations page of
http://www.g1therapeutics.com.
About G1 TherapeuticsG1 Therapeutics, Inc. is a
commercial-stage biopharmaceutical company focused on the
discovery, development and delivery of next generation therapies
that improve the lives of those affected by cancer, including the
Company’s first commercial product, COSELA™ (trilaciclib). G1 has a
deep clinical pipeline evaluating targeted cancer therapies in a
variety of solid tumors, including colorectal, breast, lung, and
bladder cancers. G1 Therapeutics is based in Research Triangle
Park, N.C. For additional information, please visit
www.g1therapeutics.com and follow us on Twitter
@G1Therapeutics.
G1 Therapeutics™ and the G1 Therapeutics logo are trademarks of
G1 Therapeutics, Inc.
Contact:Will RobertsG1 Therapeutics, Inc.Vice
President, Investor Relations & Corporate Communications(919)
907-1944 wroberts@g1therapeutics.com
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From Apr 2024 to May 2024
G1 Therapeutics (NASDAQ:GTHX)
Historical Stock Chart
From May 2023 to May 2024